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The importance of subtle gene regulation and epigenetics in determining complex human 
traits is increasingly being recognized. However, bridging the gap between 
environmental, epigenetic and genetic influences and unravelling causal relationships 
remains a big challenge. Labrie et al. now report an example of epigenetic changes 
influenced by genetic factors that are involved in the regulation of lactase gene 
expression. 
 
Intestinal lactase is required for the digestion of lactose, the major carbohydrate in 
mammalian milk, but lactase gene expression is usually down-regulated after weaning. In 
many humans, however, lactase persists into adult life allowing digestion of milk, an 
evolutionary adaptation to dietary change. Reduced intestinal lactase levels, whether due 
to developmental down-regulation or secondary loss, due for example to enteritis, results 
in incomplete digestion of lactose, which can lead to symptoms of diarrhea and flatulence 
when fresh milk is consumed. However, people who are lactase non-persistent (LNP) do 
not necessarily suffer from symptomatic lactose intolerance, as there are large inter-
individual differences due to variables such as the gut microbiome composition and gut 
transit time, as well as to a person’s sensitivity to the symptoms. 
 
While lactase persistence (LP) is clearly not a disease, a study in this issue by Labrie et 
al.1 that reports a genetic and epigenetic interplay in the regulation of lactase expression 
provides us with a curiously good example of what we may hope to find in the future for 
complex human diseases, such as diabetes, heart disease, multiple sclerosis and 
schizophrenia, for which genome-wide association studies are not yet able to explain all 
of the inherited component2.  
 
There is good evidence that the persistence of high intestinal lactase activity into adult life 
is attributable to regulation of transcription of the lactase gene (LCT). This is a primarily 
heritable trait that varies dramatically in prevalence in different parts of the world (Box 
1). In Europeans, a single nucleotide substitution (-13910 C>T) within intron 13 of 
MCM6, the gene adjacent to LCT, is strongly associated with lactase persistence. The 
C>T substitution has been shown experimentally to reside within an enhancer for LCT 
and induces increased promoter activity3-6. In Middle Eastern and African populations 
four other clearly functional alleles within the same enhancer have so far been identified 
(see for example 7) (Box 1). However, a key remaining question is how these SNPs drive 
allele specific expression in adults, while all haplotypes are expressed at high levels in 
babies.  
 
Labrie et al. use human intestinal samples from Europeans, and also conduct experiments 
in mice. In humans, having confirmed the genetically controlled inter-individual 
transcriptional differences in LCT expression, they find seven regulatory regions, in 
which changes in DNA methylation are correlated with LCT mRNA levels. DNAase 
hypersensitivity and histone modification sites (H3K27ac, H3K4me1, H3K4me3) derived 
from Epigenome Roadmap data overlap these same seven sites. In contrast, in white 
blood cells, which do not express lactase, these regions are fully methylated.  
 
The authors used CRISPR-Cas9-induced genetic deletions in human tissue culture and in 
the mouse to validate the regulatory function of these epigenetically-modified elements. 
They also mapped the promoter of a long non-coding RNA (lncRNA), LOC100507600, 
to the intron 5 region and show that it regulates lactase expression by using RNA 
interference (RNAi). 
 
The seven regions identified also include the LCT enhancer located within intron 13 of 
MCM6, which houses the functional DNA variants. Indeed, one of the most powerful 
observations in the current study relates to inter-individual differences in DNA 
methylation at this enhancer region. These show the greatest correlation with genotype for 
the known functional European LP SNP as well as SNPs that form part of the LP 
haplotype. The strongly stratified difference in modification of this enhancer region 
provides, in our view, additional evidence for the functional role of this enhancer in LP.  
 
The second very important observation is that even in adults (the only samples available) 
a significant age-related change in DNA methylation can be seen, providing for the first 
time a mechanism for age-related difference in lactase gene expression. Apart from the 
lncRNA region, there tends to be an increase in DNA modification with age for the 
ancestral haplotype and a non-significant decrease in the case of LP haplotypes.  Overall, 
modifications at LCT and MCM6 regulatory elements in enterocytes remain relatively low 
except in the MCM6 regions of the ancestral haplotype, where in intron 13 DNA 
methylation is already at about 80% even in young adults.  
 
In summary, the study provides functional evidence for several regulatory sites for LCT 
expression and reveals that lactase down-regulation is correlated with accumulation of 
transcriptionally suppressive epigenetic changes on haplotypes carrying the C-13910 
allele, while T-13910 containing haplotypes escape from epigenetic inactivation, 
facilitating lactase persistence (Fig. 1). In the future, it will be intriguing to examine DNA 
methylation profiles of fetuses, where there is low lactase expression from both LP and 
non-LP haplotypes, and of children, where expression from both LP and non LP 
haplotypes is high8. Despite the current lack of these data we now begin to get insight into 
how lactase down-regulation is effected and how non-genetic factors might occasionally 
tip the pattern of expression, such that more or less lactase may be expressed than 
predicted from genotype. 
 
The current study provides a strong rationale for further investigating how an escape from 
inactivation is brought about. It should in this context be noted that in Europeans the only 
nucleotide difference from the ancestral sequence within the LCT enhancer is 13910 C>T. 
However, in other populations, individuals who carry different functional LP alleles show 
high expression of lactase and good lactose digestion, 9-11 despite being homozygous CC 
at -13910, suggesting that the other enhancer SNPs presumably also allow escape from 
epigenetic down-regulation in a cis-acting manner.  In vitro effects observed for the 
various functional enhancer SNPs, which include differential binding of transcription 
factors, suggest that differences in the relevant binding sites in the enhancer might in turn 
lead to histone and DNA modification. Differential epigenetic changes along the crypt-
villus axis associated with transition to cellular differentiation12 and altered coordination 
of changes in transcription factor expression may play a part in this. As in all 
genetic/epigenetic studies it is difficult to determine the causal direction of the effects 
observed, but this report describes a very important step forward and emphasizes how 
age-related epigenetic changes may interact with common DNA variants that are benign 
in childhood, but associated with disease in the adult. 
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Box 1 Lactase persistence distribution assessed by the frequency of known functional 
alleles and assumed dominance of the trait. 
The pale blue segment shows the proportion of lactase non-persistence, while the other colours show LP 
accounted for by the different functional alleles described so far (see for example10,11,13,14  and references 
therein). The dark orange segments show lactase persistence attributable to the allele/haplotype studied by 
Labrie et al. The  pale grey segment is a very rough estimate of the ‘causal alleles’ that may be missing, 
assessed by genotype and phenotype frequency comparisons15. Note that in most studies lactase persistence 
is inferred indirectly from lactose tolerance tests—the physiological response to a lactose load after an 
overnight fast.  While lactose digestion tests are not 100% accurate, there is good indirect evidence that a 
few carefully tested people express high lactase levels as adults although no candidate functional DNA 
variant has been found. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1 Inverse relationship between MCM6/LCT enhancer methylation and lactase 
gene expression. Putative interactions between the enhancers and promoter are shown as arrows. Shaded 
lollipops represent levels of DNA methylation of  regulatory regions identified by Labrie et al . LP denotes 
lactase persistence haplotype and LNP denotes lactase non-persistence haplotype. 
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